Effect of 24 weeks of treatment with epalrestat, an aldose reductase inhibitor, on peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus-Reference-Cited by-同舟云学术

Effect of 24 weeks of treatment with epalrestat, an aldose reductase inhibitor, on peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus

Published:1995-05 Issue:3 Volume:17 Page:460-466
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Uchida Kenzo,Kigoshi Toshikazu,Nakano Shigeru,Ishii Takashi,Kitazawa Mitsutaka,Morimoto Shinpei

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference14 articles.

1. Hyperglycemia, polyol metabolism and complications of diabetes mellitus;Gabby;Annu Rev Med,1975

2. Glucose-induced alterations in nerve metabolism: Current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy;Greene;Diabetes Care,1985

3. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications;Greene;NEJM,1987

4. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil;Sima;NEJM,1987

5. Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphology in advanced diabetic peripheral polyneuropathy;Sima;J Diabetes Complications,1993

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N-Acetylcysteine overcomes epalrestat-mediated increase of toxic 4-hydroxy-2-nonenal and potentiates the anti-arthritic effect of epalrestat in AIA model;International Journal of Biological Sciences;2023

2. Development of Aldose Reductase Inhibitors for the Treatment of Inflammatory Disorders and Cancer: Current Drug Design Strategies and Future Directions;Current Medicinal Chemistry;2021-06-18

3. Aldo-keto reductase family 1 member B induces aortic valve calcification by activating hippo signaling in valvular interstitial cells;Journal of Molecular and Cellular Cardiology;2021-01

4. Evaluation of Efficacy and Safety of Epalrestat (150 mg) Compared to Epalrestat (50 mg) in Patients Suffering from Diabetic Peripheral Neuropathy;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2018

5. Aldo-Keto Reductases: Multifunctional Proteins as Therapeutic Targets in Diabetes and Inflammatory Disease;Advances in Experimental Medicine and Biology;2018